Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,127.86
1,393.34
1,389.26
1,349.97
1,089.77
1,240.95
1,197.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,127.86
1,393.34
1,389.26
1,349.97
1,089.77
1,240.95
1,197.03
Raw Material Cost
605.05
701.19
726.66
660.04
536.33
525.93
424.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
408.89
471.65
470.57
412.68
347.16
356.00
340.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.08
11.22
12.52
16.10
13.14
11.90
0.00
Selling and Distribution Expenses
274.98
316.55
293.79
304.66
250.19
259.73
377.13
Other Expenses
-42.00
-48.29
-48.31
-42.88
-36.03
-36.79
-34.02
Total Expenditure (Excl Depreciation)
880.03
1,017.74
1,020.45
964.71
786.52
785.66
801.85
Operating Profit (PBDIT) excl Other Income
247.8
375.6
368.8
385.3
303.2
455.3
395.20000000000005
Other Income
15.79
19.35
34.67
13.50
70.56
10.38
10.20
Operating Profit (PBDIT)
441.97
596.91
627.08
616.34
544.68
618.99
474.31
Interest
11.08
11.22
12.52
16.10
13.14
11.90
0.00
Exceptional Items
0.00
0.00
0.49
-3.04
-2.12
-1.69
0.14
Gross Profit (PBDT)
522.81
692.15
662.60
689.93
553.44
715.02
772.31
Depreciation
178.34
201.96
223.59
219.05
171.26
154.82
70.39
Profit Before Tax
252.55
383.72
391.46
378.15
358.16
450.58
404.05
Tax
46.18
73.32
75.82
72.91
73.53
90.42
85.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
206.90
315.80
315.64
305.25
284.63
360.16
319.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
206.90
315.80
315.64
305.25
284.63
360.16
319.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.53
-5.40
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
206.37
310.40
315.64
305.25
284.63
360.16
319.03
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
379.95
497.51
612.27
494.27
684.85
679.00
560.74
Earnings per share (EPS)
0.16
0.25
0.25
0.25
0.24
0.32
0.29
Diluted Earnings per share
0.16
0.25
0.25
0.25
0.24
0.32
0.29
Operating Profit Margin (Excl OI)
21.97%
26.96%
26.55%
28.43%
27.79%
36.57%
32.89%
Gross Profit Margin
38.2%
42.03%
44.27%
44.24%
48.58%
48.79%
39.63%
PAT Margin
18.34%
22.66%
22.72%
22.61%
26.12%
29.02%
26.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -19.05% vs 0.29% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -33.51% vs -1.65% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -26.21% vs -2.50% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -0.89% vs -10.40% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Perfect Medical Health Management Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
1,127.86
1,913.16
-785.30
-41.05%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,127.86
1,913.16
-785.30
-41.05%
Raw Material Cost
605.05
1,393.02
-787.97
-56.57%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
408.89
559.45
-150.56
-26.91%
Power Cost
0
0
0.00
Manufacturing Expenses
11.08
23.66
-12.58
-53.17%
Selling and Distribution Expenses
274.98
398.49
-123.51
-30.99%
Other Expenses
-42.00
-58.31
16.31
27.97%
Total Expenditure (Excl Depreciation)
880.03
1,791.51
-911.48
-50.88%
Operating Profit (PBDIT) excl Other Income
247.83
121.65
126.18
103.72%
Other Income
15.79
19.93
-4.14
-20.77%
Operating Profit (PBDIT)
441.97
354.37
87.60
24.72%
Interest
11.08
23.66
-12.58
-53.17%
Exceptional Items
0.00
-193.17
193.17
100.00%
Gross Profit (PBDT)
522.81
520.14
2.67
0.51%
Depreciation
178.34
212.78
-34.44
-16.19%
Profit Before Tax
252.55
-75.25
327.80
435.61%
Tax
46.18
32.09
14.09
43.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
206.90
-135.16
342.06
253.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
206.90
-135.16
342.06
253.08%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.53
26.85
-27.38
-101.97%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
206.37
-108.31
314.68
290.54%
Equity Capital
0
0
0.00
Face Value
0.10
0.10
0.00
Reserves
379.95
1,752.68
-1,372.73
-78.32%
Earnings per share (EPS)
0.16
-0.11
0.27
245.45%
Diluted Earnings per share
0.16
-0.11
0.27
245.45%
Operating Profit Margin (Excl OI)
21.97%
6.36%
0.00
15.61%
Gross Profit Margin
38.20%
7.19%
0.00
31.01%
PAT Margin
18.34%
-7.06%
0.00
25.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 112.79 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -19.05% vs 0.29% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 20.64 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -33.51% vs -1.65% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.62 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -26.21% vs -2.50% in Mar 2024
Annual - Interest
Interest 1.11 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -0.89% vs -10.40% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.97%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






